To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AIFM1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
294 representative clones for gene AIFM1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_004208.3   .a 1 to 2265 1 to 2265 exact RefSeq, AAA   2265/2265
(100 %)
0 diff
(100 %id)
BC139738 PCR rescued clones .a 97 to 2178 1 to 2082 exact tiling clone,   2082/2082
(100 %)
0 diff
(100 %id)
AL545607 placenta, Placenta Cot 25-normalized .a 153 to 1233 1 to 1079   fully sequenced,   1079/1079
(100 %)
17 diff
(98.5 %id)
AK000775 colon .a 165 to 2265 1 to 2101 exact tiling clone, available from FLJ, AAA   2101/2101
(100 %)
2 diff
(100.0 %id)
CR607158 fetal liver .a 172 to 2220 1 to 2049 exact     2049/2049
(100 %)
0 diff
(100 %id)
AF100928   .a 190 to 2095 1 to 1906 exact     1906/1906
(100 %)
1 diff
(100.0 %id)
BX331768 Neuroblastoma Cot 25-normalized .a 193 to 1295 33 to 1124       1092/1124
(97 %)
23 diff
(98.0 %id)
AL550264 placenta, Placenta Cot 25-normalized .a 202 to 1229 1 to 1027   fully sequenced,   1027/1027
(100 %)
3 diff
(99.8 %id)
CR606178 Placenta Cot 25-normalized .a 203 to 2224 1 to 2022 exact     2022/2022
(100 %)
0 diff
(100 %id)
CR457379   .a 232 to 2069 1 to 1838       1838/1842
(99 %)
3 diff
(99.9 %id)
BQ061576 lymph, lymphoma, cell line .a 449 to 1383 1 to 946       946/1008
(93 %)
16 diff
(98.5 %id)
BG117796 adenocarcinoma, cell line, Liver .a 459 to 1271 1 to 802       802/909
(88 %)
43 diff
(95.3 %id)
AL571252 placenta, Placenta Cot 25-normalized .a 1167 to 2232 1059 to 1   fully sequenced,   1059/1059
(100 %)
11 diff
(99.0 %id)
AL550236 placenta, Placenta Cot 25-normalized .a 1176 to 2224 1050 to 1   fully sequenced,   1050/1050
(100 %)
3 diff
(99.8 %id)
BX392084 Neuroblastoma Cot 25-normalized .a 1404 to 2263 867 to 1       867/878
(98 %)
17 diff
(98.1 %id)
NM_145812.2   .b 1 to 2253 1 to 2253 exact RefSeq, AAA   2253/2253
(100 %)
0 diff
(100 %id)
DA696481   .b 10 to 583 2 to 575   tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
DA155011 amygdala .b 48 to 612 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA608397   .b 48 to 568 2 to 522   capped   521/529
(98 %)
0 diff
(100 %id)
BC111065 Brain, fetal, whole pooled .b 58 to 2253 1 to 2196 exact tiling clone, AAA   2196/2196
(100 %)
1 diff
(100.0 %id)
BM927047 brain .b 59 to 914 1 to 861       861/1115
(77 %)
18 diff
(98.4 %id)
DA774022 brain .b 121 to 706 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DA683052   .b 123 to 652 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
AL049703   .b 136 to 2256 1 to 2121 exact tiling clone,   2121/2121
(100 %)
0 diff
(100 %id)
DA709550   .b 151 to 720 2 to 576   capped   575/575
(100 %)
6 diff
(99.0 %id)
DA208222 brain .b 166 to 738 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA305931 hippocampus .b 177 to 765 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DA071494 cerebellum .b 184 to 759 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA081762 cerebellum .b 184 to 743 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA090526 cerebellum .b 184 to 750 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA150876 amygdala .b 184 to 748 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA278388 corpus callosum .b 184 to 735 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA345123 substantia nigra .b 184 to 738 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
AK314446 kidney, tumor tissue .b 201 to 2061 1 to 1861 exact     1861/1861
(100 %)
0 diff
(100 %id)
DB171076 kidney, tumor tissue .b 201 to 778 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
H15605 whole brain .b 312 to 789 1 to 481       481/481
(100 %)
13 diff
(97.3 %id)
CB594876 Blood, promyelocytic leukemia .b 532 to 1298 1 to 772       772/985
(78 %)
14 diff
(98.6 %id)
AY795556   .b 549 to 1226 1 to 678       678/679
(99 %)
5 diff
(99.3 %id)
AY795557   .b 551 to 1226 1 to 676       676/677
(99 %)
12 diff
(98.3 %id)
BU552706 ovary, teratocarcinoma, cell line .b 609 to 1505 1 to 898       898/900
(99 %)
7 diff
(99.3 %id)
BQ364700 stomach_normal .b 624 to 1199 14 to 588       575/588
(97 %)
10 diff
(98.3 %id)
AF131759   .b 637 to 2248 1 to 1612   AAA   1612/1612
(100 %)
0 diff
(100 %id)
BF182905 large cell carcinoma, lung .b 672 to 1393 1 to 714       714/909
(78 %)
17 diff
(98.2 %id)
BQ581783 insulinoma, Pancreas .b 709 to 1335 1 to 627       627/627
(100 %)
5 diff
(99.3 %id)
AW062708 colon .b 739 to 1246 10 to 514       505/527
(95 %)
11 diff
(98.0 %id)
BQ308753 breast .b 775 to 1341 573 to 9       565/573
(98 %)
4 diff
(99.4 %id)
BG119647 adenocarcinoma, cell line, Liver .b 811 to 1522 1 to 713       713/990
(72 %)
10 diff
(99.0 %id)
BM852351 Ascites, stomach .b 811 to 1289 1 to 479       479/479
(100 %)
5 diff
(99.0 %id)
BQ300813 bladder_tumor .b 833 to 1362 527 to 2       526/527
(99 %)
5 diff
(99.1 %id)
AA134414 colon, tumor .b 886 to 1286 1 to 404       404/404
(100 %)
3 diff
(99.3 %id)
BY996968   .b 904 to 1549 10 to 655       646/655
(98 %)
1 diff
(99.9 %id)
BQ360642 ovary .b 914 to 1525 44 to 657       615/659
(93 %)
12 diff
(98.2 %id)
CF141027 CNCAP(3)T-225 cell line, Prostate .b 933 to 1362 7 to 436       430/436
(98 %)
6 diff
(98.7 %id)
TI_154171690   .b 933 to 1631 79 to 778       700/908
(77 %)
14 diff
(98.5 %id)
BG284761 adenocarcinoma, cell line, Prostate .b 939 to 1570 1 to 632       632/632
(100 %)
7 diff
(98.9 %id)
CF121261 CNCAP(3)T-225 cell line, Prostate .b 940 to 1691 1 to 749       749/749
(100 %)
6 diff
(99.2 %id)
TI_154180275   .b 945 to 1771 71 to 891       821/821
(100 %)
9 diff
(99.0 %id)
CN280461 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1010 to 1586 13 to 588       576/588
(97 %)
6 diff
(99.0 %id)
BX452477 fetal liver, Liver .b 1010 to 1667 1 to 661       661/977
(67 %)
16 diff
(98.4 %id)
TI_59393563   .b 1035 to 1880 54 to 909       856/856
(100 %)
29 diff
(96.7 %id)
BM015333 breast, mammary adenocarcinoma, cell line .b 1037 to 1880 1 to 854       854/854
(100 %)
29 diff
(96.7 %id)
BG475176 melanotic melanoma, skin .b 1042 to 1589 1 to 548       548/548
(100 %)
2 diff
(99.7 %id)
BQ065495 lymph, lymphoma, cell line .b 1057 to 1988 1 to 939       939/1009
(93 %)
23 diff
(97.8 %id)
BQ066492 lymph, lymphoma, cell line .b 1057 to 2047 1 to 999       999/999
(100 %)
21 diff
(97.9 %id)
BQ058888 lymph, lymphoma, cell line .b 1058 to 1986 1 to 937       937/1059
(88 %)
20 diff
(98.2 %id)
BQ063239 lymph, lymphoma, cell line .b 1058 to 1983 1 to 933       933/1034
(90 %)
16 diff
(98.5 %id)
BX433366 fetal liver, Liver .b 1080 to 2019 964 to 11       952/964
(98 %)
30 diff
(96.9 %id)
AV698580 hepatocellular carcinoma .b 1094 to 1742 21 to 656       636/1025
(62 %)
27 diff
(97.4 %id)
AV683442 hepatocellular carcinoma .b 1101 to 1750 1 to 643       648/660
(98 %)
24 diff
(96.4 %id)
AV685709 hepatocellular carcinoma .b 1101 to 1672 1 to 567       572/660
(86 %)
24 diff
(96.4 %id)
BF038249 adenocarcinoma, ovary .b 1101 to 1891 1 to 789       748/789
(94 %)
35 diff
(95.6 %id)
BE872403 adenocarcinoma, colon .b 1103 to 1748 1 to 641       641/886
(72 %)
9 diff
(99.0 %id)
BM789352 Ascites, stomach .b 1128 to 1648 1 to 521       521/521
(100 %)
0 diff
(100 %id)
EC484976 Prostate .b 1143 to 1247 105 to 1       105/105
(100 %)
0 diff
(100 %id)
BG281560 melanotic melanoma, skin .b 1168 to 1989 1 to 822       822/823
(99 %)
22 diff
(97.4 %id)
BG282403 melanotic melanoma, skin .b 1168 to 1989 1 to 820       820/824
(99 %)
11 diff
(98.7 %id)
BG281568 melanotic melanoma, skin .b 1168 to 1987 1 to 814       814/881
(92 %)
18 diff
(98.0 %id)
BG478728 melanotic melanoma, skin .b 1168 to 1896 1 to 731       731/731
(100 %)
5 diff
(99.4 %id)
CN280460 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1177 to 1895 5 to 723       719/723
(99 %)
0 diff
(100 %id)
BQ581468 insulinoma, Pancreas .b 1588 to 2248 675 to 15   AAA   661/661
(100 %)
0 diff
(100 %id)
H15546 whole brain .b 1815 to 2160 454 to 104   AAA   351/359
(97 %)
5 diff
(98.7 %id)
AA134415 colon, tumor .b 1823 to 2250 429 to 1       429/431
(99 %)
1 diff
(99.8 %id)
Z43296 brain, total brain .c 1 to 200 1 to 200   tiling clone,   200/200
(100 %)
2 diff
(99.0 %id)
H20712 whole brain .c 2 to 421 1 to 426   to resequence,   426/431
(98 %)
8 diff
(98.2 %id)
H17682 whole brain .c 3 to 525 1 to 530   tiling clone,   530/533
(99 %)
12 diff
(97.8 %id)
H20713 whole brain .c 1403 to 1842 467 to 17   tiling clone, to resequence, AAA   451/453
(99 %)
15 diff
(96.7 %id)
H17067 whole brain .c 1509 to 1842 356 to 17   AAA   340/358
(94 %)
12 diff
(96.7 %id)
NM_145813.1   .d 1 to 1354 1 to 1354 exact RefSeq,   1354/1354
(100 %)
0 diff
(100 %id)
AL049704   .d 155 to 1354 1 to 1200 exact tiling clone,   1200/1200
(100 %)
0 diff
(100 %id)
NM_001130847.2   .e 1 to 2471 1 to 2471 exact RefSeq,   2471/2471
(100 %)
0 diff
(100 %id)
DA023311   .e 10 to 577 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
DA268332 caudate nucleus .e 10 to 554 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA452950 tongue, tumor tissue .e 28 to 585 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB459677 testis .e 29 to 691 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
DB256723 uterus .e 29 to 601 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA797928 brain .e 30 to 566 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA976461 synovial membrane tissue from rheumatioidarthritis .e 30 to 580 2 to 552   capped   551/560
(98 %)
0 diff
(100 %id)
DB108680 thymus .e 30 to 594 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB120982 thymus .e 30 to 596 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB122568 thymus .e 30 to 574 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DB166255 thyroid gland .e 30 to 708 2 to 684   capped   683/762
(89 %)
8 diff
(99.0 %id)
DB112056 thymus .e 31 to 613 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA487567 brain .e 41 to 594 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CD637424   .e 44 to 264 220 to 2       219/220
(99 %)
0 diff
(100 %id)
CD637425   .e 44 to 264 1 to 219       219/221
(99 %)
10 diff
(95.5 %id)
BG115901 duodenal adenocarcinoma, cell line, small intestine .e 45 to 814 1 to 764       764/912
(83 %)
22 diff
(97.6 %id)
DA665418   .e 48 to 411 2 to 365   capped   364/364
(100 %)
0 diff
(100 %id)
DB109133 thymus .e 48 to 620 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB119488 thymus .e 48 to 593 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB187900 liver, tumor tissue .e 48 to 632 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BM807180 lymph, lymphoma, cell line .e 54 to 792 1 to 742       719/1112
(64 %)
21 diff
(98.2 %id)
BQ212050 melanotic melanoma, skin .e 58 to 921 1 to 876       876/877
(99 %)
20 diff
(97.8 %id)
BI826051 brain, medulla .e 60 to 783 1 to 724       724/724
(100 %)
2 diff
(99.8 %id)
TI_57173748   .e 60 to 783 28 to 751       724/751
(96 %)
7 diff
(99.1 %id)
DA550392   .e 65 to 628 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
EL951099 eyeball .e 66 to 241 11 to 185       175/185
(94 %)
6 diff
(96.8 %id)
BE887067 leiomyosarcoma, uterus .e 67 to 832 1 to 759       759/873
(86 %)
18 diff
(98.0 %id)
DA938916 Spleen .e 67 to 350 2 to 285   capped   284/284
(100 %)
0 diff
(100 %id)
BG744018 blood, natural killer cells, cell line .e 69 to 830 1 to 764       764/765
(99 %)
8 diff
(99.0 %id)
AL557331 T cells (Jurkat cell line), T cells from T cell leukemia .e 72 to 1157 1 to 1083       1083/1089
(99 %)
14 diff
(98.8 %id)
AW401864 lymph .e 74 to 518 8 to 452       445/452
(98 %)
6 diff
(98.7 %id)
DB129183 thymus .e 80 to 632 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA010153 adrenal gland .e 84 to 649 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA119854 cerebellum .e 88 to 371 2 to 285   capped   284/284
(100 %)
0 diff
(100 %id)
BE906258 epithelioid carcinoma, Pancreas .e 88 to 843 1 to 756       756/826
(91 %)
17 diff
(98.0 %id)
BU178593 melanotic melanoma, skin .e 89 to 929 1 to 847       847/870
(97 %)
20 diff
(97.8 %id)
BU517321 leiomyosarcoma, uterus .e 97 to 921 1 to 832       832/832
(100 %)
12 diff
(98.6 %id)
AW401626 lymph .e 98 to 246 1 to 149       149/149
(100 %)
5 diff
(96.7 %id)
BX384838   .e 99 to 1039 34 to 973       940/973
(96 %)
6 diff
(99.4 %id)
BM835413 stomach .e 112 to 563 1 to 452       452/452
(100 %)
0 diff
(100 %id)
DB050527 testis .e 114 to 681 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BM554259 brain, medulla .e 117 to 1013 25 to 926       902/1058
(85 %)
16 diff
(98.5 %id)
BE903161 choriocarcinoma, placenta .e 118 to 1013 19 to 926       906/1191
(76 %)
37 diff
(96.9 %id)
DA050804   .e 119 to 689 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA762687 tongue .e 119 to 689 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA925717 small intestine .e 119 to 707 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB110735 thymus .e 119 to 697 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BU161623 melanotic melanoma, skin .e 120 to 929 1 to 815       815/898
(90 %)
14 diff
(98.5 %id)
DA432609 colon .e 121 to 632 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DA053607   .e 123 to 715 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DA635283 Kidney .e 123 to 699 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BM471177 melanotic melanoma, skin .e 127 to 921 42 to 837       796/1002
(79 %)
18 diff
(98.3 %id)
DA162665 amygdala .e 129 to 669 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BE889876 leiomyosarcoma, uterus .e 131 to 844 1 to 722       722/803
(89 %)
17 diff
(97.9 %id)
BE903834 choriocarcinoma, placenta .e 133 to 738 1 to 609       609/609
(100 %)
5 diff
(99.2 %id)
BU170548 eye, retinoblastoma .e 133 to 902 1 to 774       774/861
(89 %)
12 diff
(98.7 %id)
DA152396 amygdala .e 134 to 724 2 to 594   capped   593/593
(100 %)
3 diff
(99.5 %id)
DB447708 testis .e 134 to 836 1 to 701       701/711
(98 %)
7 diff
(99.1 %id)
DA632735 Kidney .e 134 to 702 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA620776   .e 135 to 724 2 to 592   capped   591/591
(100 %)
2 diff
(99.7 %id)
BG400753 Kidney .e 150 to 888 1 to 738       741/741
(100 %)
20 diff
(97.4 %id)
DA627357 Kidney .e 151 to 648 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
AL543045 placenta, Placenta Cot 25-normalized .e 152 to 1087 1 to 932       932/1024
(91 %)
5 diff
(99.6 %id)
CT002333 T-Lymphocytes .e 156 to 902 1 to 750       748/753
(99 %)
5 diff
(99.4 %id)
DA620510   .e 160 to 759 2 to 602   capped   601/601
(100 %)
3 diff
(99.6 %id)
BM753957 stomach .e 162 to 278 1 to 114       114/114
(100 %)
3 diff
(97.4 %id)
BM784275 stomach .e 162 to 747 1 to 586       586/586
(100 %)
2 diff
(99.7 %id)
DA050532   .e 163 to 744 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA566056 heart .e 163 to 729 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA622665 Kidney .e 163 to 707 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA639285 Liver .e 163 to 648 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DB037557 testis .e 163 to 727 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BM548814 duodenal adenocarcinoma, cell line, small intestine .e 165 to 1163 1 to 1010       1010/1056
(95 %)
67 diff
(93.7 %id)
DA626930 Kidney .e 165 to 707 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA385855 thalamus .e 166 to 750 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA550115   .e 166 to 733 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA015704 adrenal gland .e 167 to 730 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA025187   .e 168 to 743 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB187592 liver, tumor tissue .e 170 to 739 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BI597657 brain, hypothalamus .e 171 to 921 1 to 750       750/755
(99 %)
7 diff
(99.1 %id)
BI835393 pooled pancreas and spleen .e 173 to 962 1 to 792       792/793
(99 %)
3 diff
(99.7 %id)
BM013834 breast, mammary adenocarcinoma, cell line .e 173 to 925 13 to 766       754/766
(98 %)
10 diff
(98.7 %id)
TI_57164803   .e 173 to 962 33 to 824       792/825
(96 %)
9 diff
(99.0 %id)
TI_59391771   .e 173 to 925 131 to 884       754/766
(98 %)
10 diff
(98.7 %id)
DB122000 thymus .e 174 to 726 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
CV811362 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e 175 to 844 1 to 670       670/876
(76 %)
9 diff
(99.0 %id)
TI_45213417   .e 176 to 921 122 to 866       745/871
(85 %)
9 diff
(99.0 %id)
DA052399   .e 177 to 734 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB492540 hypothalamus .e 179 to 892 1 to 714       714/714
(100 %)
1 diff
(99.9 %id)
DA634826 Kidney .e 181 to 760 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DN990979 brain, whole brain .e 181 to 891 1 to 710       710/710
(100 %)
7 diff
(99.1 %id)
AW247071 lung, small cell carcinoma .e 182 to 756 1 to 575       575/575
(100 %)
7 diff
(98.8 %id)
DA623964 Kidney .e 184 to 726 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA634613 Kidney .e 184 to 750 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA640100 Liver .e 184 to 721 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
CD704372 normal nasopharynx .e 186 to 806 15 to 635       621/635
(97 %)
6 diff
(99.1 %id)
AI791597 Kidney .e 187 to 687 1 to 501       501/501
(100 %)
0 diff
(100 %id)
CX787225 human embryonic stem cells .e 188 to 1003 1 to 816       816/816
(100 %)
0 diff
(100 %id)
DA642446 Liver .e 188 to 824 2 to 638   capped   637/637
(100 %)
0 diff
(100 %id)
BQ212417 melanotic melanoma, skin .e 189 to 935 39 to 790       752/883
(85 %)
26 diff
(97.1 %id)
AL532424 brain, fetal liver, Liver, neuroblastoma cells .e 193 to 1216 23 to 1044       1022/1108
(92 %)
18 diff
(98.4 %id)
BM464026 melanotic melanoma, skin .e 193 to 929 1 to 740       740/1039
(71 %)
10 diff
(99.1 %id)
BE796156 lung, small cell carcinoma .e 194 to 1009 1 to 803       803/939
(85 %)
22 diff
(97.7 %id)
BU158691 embryonal carcinoma, cell line, testis .e 195 to 994 1 to 823       823/830
(99 %)
19 diff
(97.8 %id)
BQ223394 melanotic melanoma, skin .e 195 to 1056 1 to 873       873/880
(99 %)
18 diff
(98.0 %id)
DA633183 Kidney .e 196 to 781 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
CR988469 T-Lymphocytes .e 204 to 1022 1 to 820       818/820
(99 %)
2 diff
(99.8 %id)
CN280459 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 206 to 501 1 to 296       296/296
(100 %)
0 diff
(100 %id)
BM921817 pooled brain, lung, testis .e 206 to 1157 12 to 972       961/977
(98 %)
18 diff
(98.2 %id)
BQ434120 melanotic melanoma, skin .e 208 to 1011 1 to 815       815/899
(90 %)
15 diff
(98.4 %id)
BG386390 adenocarcinoma cell line, colon .e 210 to 922 1 to 709       709/953
(74 %)
14 diff
(98.6 %id)
DA043011 bladder .e 218 to 784 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DQ016498   .e 224 to 2471 1 to 2248 exact tiling clone,   2248/2248
(100 %)
0 diff
(100 %id)
CA388765 eye, RPE/choroid .e 227 to 732 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CX870495 embryonic stem .e 231 to 1044 1 to 814       814/814
(100 %)
0 diff
(100 %id)
BG437720 large cell carcinoma, lung .e 243 to 1013 1 to 775       775/857
(90 %)
11 diff
(98.8 %id)
AL134627 brain .e 246 to 804 1 to 559       559/559
(100 %)
0 diff
(100 %id)
BQ213180 melanotic melanoma, skin .e 246 to 1089 1 to 848       848/891
(95 %)
15 diff
(98.4 %id)
AI733101 Kidney .e 337 to 821 485 to 1       485/485
(100 %)
0 diff
(100 %id)
BG386433 adenocarcinoma cell line, colon .e 384 to 1089 1 to 710       710/862
(82 %)
16 diff
(98.2 %id)
BG387263 adenocarcinoma cell line, colon .e 384 to 1038 1 to 653       655/941
(69 %)
14 diff
(98.6 %id)
BG115219 duodenal adenocarcinoma, cell line, small intestine .e 403 to 1089 1 to 685       685/778
(88 %)
9 diff
(98.9 %id)
BQ217628 melanotic melanoma, skin .e 411 to 1199 1 to 793       793/896
(88 %)
11 diff
(98.8 %id)
TI_154171017   .e 504 to 1088 90 to 678       589/1042
(56 %)
10 diff
(99.1 %id)
TI_59390140   .e 571 to 1177 101 to 713       613/785
(78 %)
13 diff
(98.4 %id)
AA907899 Kidney .e 672 to 819 148 to 1       148/148
(100 %)
0 diff
(100 %id)
BE384518 melanotic melanoma, skin .e 1402 to 2133 1 to 721       721/748
(96 %)
13 diff
(98.3 %id)
BQ268360 insulinoma, Pancreas .e 1413 to 2030 1 to 618     Submitted on the opposite strand 618/618
(100 %)
0 diff
(100 %id)
AL579393 T cells (Jurkat cell line), T cells from T cell leukemia .e 1417 to 2341 962 to 49   AAA   914/916
(99 %)
27 diff
(97.1 %id)
AA384219 thyroid gland .e 1421 to 1723 1 to 303       303/303
(100 %)
0 diff
(100 %id)
BU190622 melanotic melanoma, cell line, skin .e 1471 to 2358 1 to 895       895/909
(98 %)
21 diff
(97.7 %id)
BQ680227 melanotic melanoma, cell line, skin .e 1471 to 2204 1 to 736       736/921
(79 %)
2 diff
(99.8 %id)
BQ679894 melanotic melanoma, cell line, skin .e 1471 to 2204 1 to 740       740/981
(75 %)
9 diff
(99.1 %id)
BQ684292 melanotic melanoma, cell line, skin .e 1471 to 2201 1 to 737       737/898
(82 %)
9 diff
(99.0 %id)
BU839306 melanotic melanoma, cell line, skin .e 1471 to 2204 1 to 737       737/926
(79 %)
4 diff
(99.6 %id)
BQ676103 melanotic melanoma, cell line, skin .e 1471 to 2204 1 to 735       735/955
(76 %)
2 diff
(99.8 %id)
BU196703 melanotic melanoma, cell line, skin .e 1472 to 2313 26 to 875       850/912
(93 %)
20 diff
(97.9 %id)
BM791856 Ascites, stomach .e 1479 to 2189 1 to 711       711/711
(100 %)
1 diff
(99.9 %id)
BG674220 skin .e 1484 to 2380 1 to 910       910/991
(91 %)
28 diff
(97.2 %id)
AL569834 placenta, Placenta Cot 25-normalized .e 1508 to 2434 927 to 1       927/994
(93 %)
6 diff
(99.4 %id)
BG696814 skin .e 1509 to 2328 1 to 819       819/821
(99 %)
5 diff
(99.4 %id)
BG744689 blood, natural killer cells, cell line .e 1513 to 2391 902 to 24       879/904
(97 %)
13 diff
(98.6 %id)
BX114670 placenta .e 1559 to 2350 1 to 792       792/792
(100 %)
0 diff
(100 %id)
BM823862 Ascites, stomach .e 1608 to 2136 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CD637427   .e 1614 to 2296 691 to 9       683/691
(98 %)
0 diff
(100 %id)
TI_154102175   .e 1618 to 2463 920 to 80   AAA   841/953
(88 %)
5 diff
(99.5 %id)
TI_154132516   .e 1639 to 2463 926 to 105   AAA   822/822
(100 %)
30 diff
(96.4 %id)
BI762702 pooled colon, kidney, stomach .e 1655 to 2469 1 to 816       816/843
(96 %)
7 diff
(99.2 %id)
TI_57150750   .e 1655 to 2469 30 to 845       816/938
(86 %)
13 diff
(98.7 %id)
BM040977 Kidney, Wilms' tumor, cell line .e 1656 to 2038 1 to 383   fully sequenced,   383/383
(100 %)
1 diff
(99.8 %id)
BQ772364 Chondrosarcoma Cell line .e 1703 to 2463 779 to 19   AAA   761/761
(100 %)
1 diff
(99.9 %id)
BX095724 germinal center B cell .e 1716 to 2440 1 to 725       725/725
(100 %)
0 diff
(100 %id)
BE740380 adenocarcinoma cell line, ovary .e 1720 to 2259 1 to 540       540/540
(100 %)
0 diff
(100 %id)
CA445404 Chondrosarcoma, Left Pubic Bone .e 1739 to 2463 742 to 19   AAA   724/728
(99 %)
1 diff
(99.9 %id)
TI_227715368   .e 1741 to 2463 817 to 95   AAA   723/975
(74 %)
0 diff
(100 %id)
CD365835 Alveolar Macrophage, lung .e 1743 to 2463 739 to 19   AAA   721/721
(100 %)
0 diff
(100 %id)
BQ009846 Chondrosarcoma, Left Pubic Bone .e 1745 to 2463 737 to 19   AAA   719/719
(100 %)
0 diff
(100 %id)
DB512805 testis .e 1757 to 2463 1 to 706     Submitted on the opposite strand 706/706
(100 %)
7 diff
(99.1 %id)
DB563562 hypothalamus .e 1759 to 2462 1 to 703     Submitted on the opposite strand 703/704
(99 %)
2 diff
(99.8 %id)
AV699322 hepatocellular carcinoma .e 1760 to 2462 705 to 1       705/710
(99 %)
18 diff
(97.5 %id)
TI_154035600   .e 1779 to 2463 744 to 79   AAA   666/777
(85 %)
30 diff
(96.2 %id)
BM708034 eye, RPE and Choroid .e 1780 to 2038 1 to 259   fully sequenced,   259/259
(100 %)
0 diff
(100 %id)
AW194103 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 1789 to 2464 677 to 1       677/678
(99 %)
9 diff
(98.7 %id)
BF002481 colon, colon tumor, RER+ .e 1812 to 2463 652 to 1       652/652
(100 %)
1 diff
(99.9 %id)
DB636712 testis .e 1814 to 2463 1 to 650     Submitted on the opposite strand 650/650
(100 %)
0 diff
(100 %id)
EL952863 eyeball .e 1815 to 2415 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
AW518690 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1821 to 2463 657 to 15   AAA   643/643
(100 %)
13 diff
(98.0 %id)
BM693337 eye, Retina Foveal and Macular .e 1833 to 2038 1 to 206   fully sequenced,   206/206
(100 %)
0 diff
(100 %id)
BF448095 Kidney .e 1842 to 2466 626 to 1       626/626
(100 %)
4 diff
(99.4 %id)
BF739874 Kidney .e 1851 to 2468 620 to 1       620/620
(100 %)
2 diff
(99.7 %id)
BE465647 malignant melanoma, metastatic to lymphnode, skin .e 1854 to 2466 613 to 2       612/613
(99 %)
1 diff
(99.9 %id)
AW575036 lymph .e 1871 to 2463 610 to 18   AAA   593/593
(100 %)
0 diff
(100 %id)
AA570483 Schwannoma tumor .e 1888 to 2463 603 to 28   AAA   576/576
(100 %)
0 diff
(100 %id)
BU161911 leiomyosarcoma, uterus .e 1894 to 2463 1 to 570       570/570
(100 %)
0 diff
(100 %id)
BQ001037 lung, Metastatic Chondrosarcoma .e 1898 to 2463 584 to 19   AAA   566/566
(100 %)
0 diff
(100 %id)
AI950034 2 pooled tumors (clear cell type), Kidney .e 1970 to 2467 511 to 14   AAA   498/498
(100 %)
0 diff
(100 %id)
BM041648 Kidney, Wilms' tumor, cell line .e 1977 to 2391 421 to 6   fully sequenced,   416/421
(98 %)
0 diff
(100 %id)
BU731432 eye, RPE and Choroid .e 1977 to 2463 505 to 19   fully sequenced, AAA   487/487
(100 %)
0 diff
(100 %id)
BM668612 eye, Retina Foveal and Macular .e 1977 to 2468 510 to 19   fully sequenced, AAA   492/492
(100 %)
1 diff
(99.8 %id)
AI872396 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1985 to 2463 479 to 1       479/479
(100 %)
0 diff
(100 %id)
AI978692 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 1990 to 2466 477 to 1       477/477
(100 %)
0 diff
(100 %id)
AW250423 lung, small cell carcinoma .e 1992 to 2463 482 to 11   AAA   472/472
(100 %)
0 diff
(100 %id)
CA444039 Fibrosarcoma .e 1994 to 2463 488 to 19   AAA   470/470
(100 %)
0 diff
(100 %id)
DB382232 thyroid gland .e 2005 to 2463 459 to 1       459/493
(93 %)
4 diff
(99.2 %id)
AI709015 colon .e 2021 to 2461 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI521711 Kidney .e 2028 to 2468 461 to 21   AAA   441/441
(100 %)
0 diff
(100 %id)
CA427387 Cell Line, Chondrosarcoma .e 2034 to 2468 453 to 19   AAA   435/435
(100 %)
0 diff
(100 %id)
AI352315 pooled germ cell tumors .e 2043 to 2469 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AI635661 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 2048 to 2465 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AI554225 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 2049 to 2463 428 to 14   AAA   415/415
(100 %)
0 diff
(100 %id)
AI284946 adenocarcinoma, colon .e 2062 to 2463 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AA481316 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2072 to 2463 417 to 26   AAA Submitted on the opposite strand 392/392
(100 %)
0 diff
(100 %id)
AI753373 bone marrow stroma .e 2095 to 2463 389 to 21   AAA   369/369
(100 %)
0 diff
(100 %id)
AI360370 anaplastic oligodendroglioma, brain .e 2109 to 2466 358 to 1       358/358
(100 %)
0 diff
(100 %id)
BQ012199 placenta .e 2110 to 2463 372 to 19   AAA   354/354
(100 %)
0 diff
(100 %id)
AA913640 Kidney .e 2125 to 2463 356 to 18   AAA   339/339
(100 %)
0 diff
(100 %id)
AI701951 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 2176 to 2463 299 to 12   AAA   288/288
(100 %)
0 diff
(100 %id)
AA907827 pooled .e 2184 to 2454 271 to 1       271/271
(100 %)
0 diff
(100 %id)
BQ230638 epithelioid carcinoma, Pancreas .e 2202 to 2463 1 to 262   AAA   262/262
(100 %)
0 diff
(100 %id)
AA846145 parathyroid gland, parathyroid tumor .e 2206 to 2468 275 to 13   AAA   263/263
(100 %)
0 diff
(100 %id)
AI018039   .e 2223 to 2463 264 to 24   AAA   241/241
(100 %)
0 diff
(100 %id)
AI687274 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 2261 to 2466 206 to 1       206/206
(100 %)
0 diff
(100 %id)
AA496397 ovarian tumor, ovary .e 2288 to 2451 1 to 164   fully sequenced,   164/164
(100 %)
0 diff
(100 %id)
AA496348 ovarian tumor, ovary .e 2371 to 2465 95 to 1   fully sequenced,   95/95
(100 %)
0 diff
(100 %id)
AW059616   .e 2384 to 2463 80 to 1       80/80
(100 %)
0 diff
(100 %id)
DQ016496   .f 1 to 1925 1 to 1925 exact tiling clone,   1925/1925
(100 %)
0 diff
(100 %id)
NM_001130846.1   .f 1 to 1925 1 to 1925 exact RefSeq,   1925/1925
(100 %)
0 diff
(100 %id)
BG675614 skin, squamous cell carcinoma .f 323 to 918 1 to 596       596/596
(100 %)
0 diff
(100 %id)
BG985116 colon_normal .f 606 to 963 404 to 46       359/404
(88 %)
0 diff
(100 %id)
AI834231 head_neck .f 754 to 1002 1 to 250       250/253
(98 %)
2 diff
(99.3 %id)
DQ016500   .g 1 to 2105 1 to 2105 exact tiling clone,   2105/2105
(100 %)
0 diff
(100 %id)
DB164899 thymus .h 1 to 587 2 to 588   tiling clone, capped   587/587
(100 %)
1 diff
(99.9 %id)
CV353670 stomach_normal .h 72 to 498 9 to 436   tiling clone,   428/449
(95 %)
6 diff
(98.7 %id)
DB347083 thymus .h 1269 to 1801 533 to 1   tiling clone,   533/533
(100 %)
1 diff
(99.9 %id)
DA214020 brain .i 1 to 541 2 to 543 R21X T22D V23R C24V V25R ... tiling clone, capped   542/542
(100 %)
2 diff
(99.7 %id)
BY993946   .i 125 to 722 15 to 612   tiling clone,   598/612
(97 %)
7 diff
(98.9 %id)
DB125877 thymus .j 1 to 571 2 to 573   tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
GD141829   .j 348 to 509 1 to 162       162/165
(98 %)
7 diff
(95.8 %id)
GD143279   .j 349 to 496 1 to 148   AAA   148/148
(100 %)
2 diff
(98.7 %id)
GD141972   .j 353 to 509 6 to 162       157/164
(95 %)
11 diff
(93.3 %id)
BX955463   .k-u 1 to 484 1 to 485 Q29A N30K C31L T32Y C33L ... tiling clone,   485/485
(100 %)
1 diff
(99.8 %id)
BE932835 head_neck .l-u 1 to 224 245 to 23   tiling clone,   223/257
(86 %)
0 diff
(100 %id)
CN270068 embryonic stem cells, DMSO-treated H9 cellline .l-u 46 to 301 1 to 256 exact tiling clone,   256/256
(100 %)
0 diff
(100 %id)
357 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI